Author:
Zhu Lei,Mok Sachel,Imwong Mallika,Jaidee Anchalee,Russell Bruce,Nosten Francois,Day Nicholas P.,White Nicholas J.,Preiser Peter R.,Bozdech Zbynek
Publisher
Springer Science and Business Media LLC
Reference74 articles.
1. Arama, C. & Troye-Blomberg, M. The path of malaria vaccine development: challenges and perspectives. J. Intern. Med. 275, 456–466 (2014).
2. Lorenz, V., Karanis, G. & Karanis, P. Malaria vaccine development and how external forces shape it: an overview. Int. J. Environ. Res. Public. Health 11, 6791–6807 (2014).
3. Hussain, M. M., Sohail, M., Abhishek, K. & Raziuddin, M. Investigation on Plasmodium falciparum and Plasmodium vivax infection influencing host haematological factors in tribal dominant and malaria endemic population of Jharkhand. Saudi. J Biol. Sci. 20, 195–203 (2013).
4. Anstey, N. M., Douglas, N. M., Poespoprodjo, J. R. & Price, R. N. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv. Parasitol. 80, 151–201 (2012).
5. Baird, J. K. Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria. Travel Med. Infect. Dis. 11, 60–65 (2013).
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献